(PDF) PReS-FINAL-2002: Adverse Events During Anti-TNF

PReS-FINAL-2002: Adverse Events During Anti-TNF Therapy in Patients With JIA

Pediatric Rheumatology - United Kingdom

doi 10.1186/1546-0096-11-s2-o5

Full Text

Abstract

Available in full text

Categories

Date

December 1, 2013

Authors

Publisher

Springer Science and Business Media LLC

Related search

Review Article: Managing the Adverse Events Caused by Anti-TNF Therapy in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

PReS-FINAL-2058: Lipid Peroxides, Lipophuscin, Sulfhydryl Groups and TOS in Children With JIA

Pediatric Rheumatology

English

Original Paper Autoimmunogenicity During Anti-TNF Therapy in Patients With Psoriasis and Psoriatic Arthritis

Postepy Dermatologii I Alergologii

English

PReS-FINAL-2240: Serum Amyloid Protein a Concentration in CAPS Patients Treated With Anti IL1Β

Pediatric Rheumatology

English

PReS-FINAL-2108: Long-Term Outcome of 114 Adult JIA Patients in a Non-Pediatric Rheumatology Institute in Japan

Pediatric Rheumatology

English

PReS-FINAL-1005: Hypertransaminasemia in Systemic Juvenile Idiopathic Arthritis During Anti-Interleukin 1 Treatment

Pediatric Rheumatology

English

Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden

Cancer Research

English

PReS-FINAL-2029: Long-Term Follow-Up of Patients With Juvenile Idiopathic Arthritis (JIA) in a Single Center: A Systematic Chart Review

Pediatric Rheumatology

English

632 Cutaneous Immune-Related Adverse Events in 1,857 Patients Treated With Anti-Pd-1 Therapy at an Academic Center

Journal of Investigative Dermatology

Molecular Biology

English